SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $69.4 million in its second quarter.

On a per-share basis, the Singapore-based company said it had a loss of 34 cents.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The biopharmaceutical company posted revenue of $2.3 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $8.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WVE at https://www.zacks.com/ap/WVE